Axim Biotechnologies Inc. (OTCMKTS: AXIM) has appointed Kelly K Nichols to its Medical Advisory Board. Nichols joins the company’s other Advisory Board members, including Laura Periman,...
Axim Biotechnologies Inc (OTCMKTS: AXIM) has appointed a new member to its Medical Advisory Board. Henry D. Perry, M.D, the appointee, is the third member hired...
Dry Eye Disease (DED) affects more than 344 million people worldwide, and the number is growing in both young and old adults. Hence, clinicians have found...
Dry Eye Disease (DED) impacts increase with age and can significantly impair quality of life and visual acuity. The condition occurs when a person’s tears are...
AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has finalized pre-clinical drug studies on the patent waiting for compound SPX-1009, showing malignant metastatic melanoma cells suppression. Dr. Douglas Lake’s...
